Lothar Haeberle

Abstract PD1-02: Cancer predisposition genes in metastatic breast cancer – Association with metastatic pattern, prognosis, patient and tumor characteristics

Steven N. Hart, Chunling Hu, Peter A. Fasching, 2018 .

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Michael Jones, Peter Kraft, Arnaud Droit, 2017, Nature Genetics.

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

Peter A Fasching, Arndt Hartmann, Matthias W Beckmann, 2011, BMC Cancer.

Mammographic density as a risk factor for breast cancer in a German case–control study

Alexander Cavallaro, Michael Uder, Thomas Wittenberg, 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer

Kerstin Amann, L. Haeberle, B. Wullich, 2012, BJU international.

The contributions of breast density and common genetic variation to breast cancer risk.

Karla Kerlikowske, Kristen S Purrington, Elad Ziv, 2015, Journal of the National Cancer Institute.

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Patrick Neven, Peter Kraft, Nazneen Rahman, 2015 .

PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS

Dong Liang, Jane E. Carpenter, Peter Kraft, 2016 .

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

Michael Jones, Julian Peto, Thomas Brüning, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

Matthias W. Beckmann, Peter A. Fasching, Nur Aishah Mohd Taib, 2014, Nature Communications.